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Abstract
Currently, porto‐mesenteric vein resection is a standard procedure at high‐volume pan‐
creatic centers. Experience in vascular surgery is indispensable for a modern pancreatic 
surgeon. Nowadays, only arterial resections still are a controversial issue. Nevertheless, 
attempts at resection involving reconstruction of the main arteries such as the coeliac 
axis, hepatic artery, and superior mesenteric artery (SMA) have been reported, although 
in small case series. An overview of the historical and contemporary methods for surgical 
management of superior mesenteric/portal vein involvement as well as arterial involve‐
ment by pancreatic cancer is presented. We compare the data from the literature with our 
data based on the examination and long‐term follow‐up of more than 300 radical pan‐
creatic resections. Seventy‐two of the presented patients underwent pancreatic resection 
with simultaneous vascular resection—SMPV in 65 cases (44 with resection of the portal 
vein, 15 with resection of the superior mesenteric vein, 6 with resection of the porto‐
mesenterial confluence), arterial in 2 and partial resections of IVC in 5 cases. Combined 
vascular resections were done in three cases. Both groups PVR and PR showed similarly 
close results in complication rates, mortality, and morbidity. Three and 5 years survival 
rates were 42 and 38% in PD group and 28 and 19% in the PVR group. The vascular resec‐
tion must be performed only upon carefully selected patients with data for presence of 
resectable tumors or tumors with borderline resectability from the preoperative imaging 
studies. The prompt management of pancreatic cancer with vascular involvement should 
involve multidisciplinary consultation in high‐volume centers.
Keywords: pancreatic cancer, vascular resections, borderline resectability, venous 
reconstruction
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1. Introduction
Nowadays, radical surgical treatment remains the only potentially curative treatment for 
patients with pancreatic cancer. Radical surgical resection followed by adjuvant chemo‐
therapy can be performed in about 20% of all pancreatic ductal adenocarcinoma (PDAC) 
patients by the time of diagnosis and quite often is the only chance for long‐term survival 
of the patients, with an average 5‐year survival of 20–25% [1, 2]. More than 80 % of them 
are unresectable at the moment of diagnosis due to invasion of retroperitoneal tissue, por‐
tal vein (PV)/superior mesenteric vein (SMV), invasion of mesenteric artery, presence of 
liver or peritoneal metastases, or inability to sustain major surgical resection. As a result of 
the development of surgical techniques and technologies, extended operations, including 
vascular resections, have become more frequently performed in specialized centers [3]. 
This has led to a significant change in pancreatic surgery and has enlarged the border of 
resectability and ensured the possibility to achieve a curative surgical approach combined 
with neoadjuvant and adjuvant treatment strategies in patients with pancreatic cancer. 
Pancreatic carcinoma is characterized with high biological activity and early involvement 
of retroperitoneal tissue, lymph nodes, and peripancreatic blood vessels. The majority of 
pancreatic cancers are diagnosed at an advanced stage. Between 30 and 35% of them are 
classified as unresectablebecause of the isolated involvement of superior mesenteric/portal 
vein (Figure 1) [4]. For the first time the idea for resection of the portal vein for the sake 
of complete removal of the tumor was presented systematically by Fortner [5]. Currently, 
porto‐mesenteric vein resection is a standard procedure at high‐volume pancreatic cen‐
ters. Experience in vascular surgery is indispensable for a modern pancreatic surgeon. 
Nowadays, only arterial resections are still a controversial issue. Nevertheless, attempts 
at resection involving reconstruction of the main arteries such as the coeliac axis, hepatic 
artery, and superior mesenteric artery (SMA) have been reported, although in small case 
series [6].
Figure 1. Resectability of pancreatic cancer patients at the time of initial diagnosis [4].
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2. History
Moore et al. performed the first superior mesenteric vein (SMV) resection and reconstruction, 
thus making the base for the treatment of locally advanced pancreatic cancer with  aggressive 
surgery [7]. Twelve years later (1963), Asade et al. published their results, followed by Fortner 
who first described a”regional pancreatectomy” involving total pancreatectomy, radical lymph 
node clearance, combined portal vein resection (Type 1), and/or combined arterial resection 
and reconstruction (Type 2) [6, 8]. These surgical interventions carried a greater morbidity 
and mortality than conventional surgery, so lately they were abandoned. Fuhrman et al. were 
the first to report that infiltration of the portal vein/SMV was not a function of the biological 
aggressiveness of the tumor but of the proximity of the tumor to the pancreatic head [9].
With the improvement of surgical technique, anesthesia, and critical care support, the interest 
in vascular resection in cases with isolated involvement of the portal vein (PV) and/or supe‐
rior mesenteric vein (SMV) in locally advanced pancreatic cancer has gradually been renewed 
during the last decade (Figure 2) [3]. There are numerous reports on portal vein resection in 
locally advanced pancreatic cancer in the last decade, but still the results are conflicting [10–17]. 
Nowadays, it is accepted that the pancreatoduodenectomy with vein resection does not increase 
the postoperative risk, but there are still no reliable proofs that it significantly improves survival.
Figure 2. Improvement of surgical results for pancreatic cancer [3].
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3. Rationale in vascular resections
3.1. Pro
Surgeons have gradually pushed the boundaries in surgical resection thanks to the advance‐
ments in oncology and critical care. Unfortunately, PDVR has not yet been generally accepted 
and applied as surgical management of patients with locally advanced adenocarcinoma of the 
head of the pancreas, despite of the growing evidence.
3.2. Cons
Pancreatic carcinoma is characterized with high biological activity and early involvement of 
retroperitoneal tissue, lymph nodes, and peripancreatic blood vessels. Vascular involvement 
is frequently combined with invasion in neural plexus so clear resection margin could not be 
achieved. Vascular resections especially arterial ones add an additional level of complexity 
to the usually difficult pancreatic surgery without clear impact on the long‐term survival 
rates.
4. Indications for vascular resection
Extended surgical approaches, such as vascular and multivisceral resections, have become 
commonly performed in PDAC due to the improvement of surgical technique and intensive 
care, as well as the exact complications management [18].
Combined portal vein resection with pancreatectomy should be considered in order to 
achieve clear resection margins on the basis of preoperative imaging in cases suspectable 
of invasion of the portal vein rather than making the decision purely on operative findings. 
All patients should undergo contrast‐enhanced tomography (CT) as routine preoperative 
work up. The development of multislice multidetector computed axial tomography allows 
imaging of the whole pancreas in peak contrast intensification. Additionally, the information 
from the CT may be processed for acquiring of three‐dimensional images and visualization 
of different view planes. Spiral computed axial tomography with i.v. contrast and technique 
for thin sections may accurately assess the relations of tumor formation with low density to 
the celiac trunk, superior mesenteric artery, and superior mesenteric‐portal vein confluence. 
Magnetic resonance imaging (MRI), endoscopic ultrasound scans (EUS), and laparoscopy 
should be performed on an individual patient basis depending on the multidisciplinary team 
(MDT) discussion. MRI is usually recommended when there is a suspicion of liver metastases 
present.
According to Ishikawa et al. and Nakao and coworker, the indications are limited to uni‐
lateral (<180°) segmental vascular involvement [19, 20]. Attention was especially paid to 
the exclusion of the cases with deep retroperitoneal invasion, defined by the absence of 
intact connective tissue between the tumor and the right lateral side of the superior mes‐
enteric artery. Isolated arterial involvement is not accepted as an absolute contraindication. 
Endoscopic ultrasonography (EUS) at this stage is more reliable regarding detection of inva‐
sion in the porto‐mesenteric system and is a standard procedure in the specialized medical 
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centers. Tumors with simultaneous involvement of several blood vessels or massive retro‐
peritoneal invasion are treated as resectable only in the case of sensitivity to neoadjuvant 
chemotherapy.
Preoperative evaluation of resectability should be based on a computed tomography (CT) 
scan with a pancreas‐specific protocol, for example, a “hydropancreas” CT, according to 
these recommendations. Three grades of resectability can be defined for localized PDAC—
“resectable,” “borderline resectable,” and “unresectable” [21]. A tumor is defined as resectable 
when no vascular attachment (no distortion of the venous structures and clearly preserved 
fat planes toward the arteries) is present. The resectability is accepted as borderline when 
distortion/narrowing/occlusion of the mesentericoportal veins with a technical possibility of 
reconstruction on the proximal and distal margin of the veins or a semicircumferential abut‐
ment (≤180°) of the superior mesenteric artery (SMA) or an attachment at the hepatic artery 
without the celiac axis is diagnosed—see below. The locally advanced, surgically unresect‐
able tumors are defined as those with infiltration of celiac trunk and/or superior mesenteric 
artery or as tumors involving the superior mesenteric vein, portal vein, or their confluence. 
The term “encasement” indicates that the tumor is undistinguishable from the blood vessel 
for more than 180° of the circumference of the latter. A tumor is defined as unresectable when 
it presents with the presence of distant metastases, greater than 180° SMA encasement, any 
celiac abutment, unreconstructible SMV/portal vein, aortic/IVC invasion or encasement, or 
metastases to lymph nodes beyond the field of resection.
Despite the development of pancreatic imaging, distinguishing between the resectable (stage 
I and II) and locally advanced (stage III) disease may be difficult and these cases are named 
with the term “borderline resectability.” Vascular resections are usually required in cases 
often described as with “borderline resectable” findings.
The definition of borderline resectable carcinoma according to an expert consensus statement 
from 2009 [22] includes short SMV/PV involvement with free proximal and distal venous seg‐
ments, permitting secure reconstruction and SMA < 180° or short hepatic artery involvement 
with intact truncus coeliacus. The difference from the M. D. Anderson Group classification is 
in considering tumors, encasing or abutting (depending on the degree of tumor‐vessel inter‐
face) the SMV/PV borderline but not resectable [23].
Effected vessel AHPBA/SSAT/SSO/NCCN [1] MD Anderson [2] Alliance [3]
SMV/PV Abutment, impingement, 
encasement of the SMV/PV or 
short segment venous occlusion
Occlusion Tumor‐vessel interface ≥180° of vessel wall 
circumference, and/or reconstructable 
occlusion
SMA Abutment Abutment Tumor‐vessel interface <180° of vessel wall 
circumference
HA Abutment or short segment 
encasement
Abutment or short 
segment encasement
Reconstructable short segment interface of 
any degree between tumor and vessel wall
CA Uninvolved Abutment Tumor‐vessel interface <180° of vessel wall 
circumference
Table 1. CT criteria for borderline resectable pancreatic cancer.
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The TVI‐classification of Tran Cao et al. [24] considers the radiographic tumor‐vein circumfer‐
ential interface and its value as a predictive factor for concomitant vessel resection.
A consensus statement standardizing the definition of the term “borderline resectability” in 
accordance with the guidelines of the National Comprehensive Cancer Network (NCCN) as 
well as the definition of extended resections published by the International Study Group for 
Pancreatic Surgery (ISGPS) (Table 1) [21–23].
The approach should be different when borderline findings in venous and arterial vessel 
involvement are diagnosed. No neoadjuvant treatment is recommended in venous borderline 
resectability. Upfront surgery should be performed and, if the intraoperative finding matches 
the presumed borderline situation as defined above, completed as an en bloc tumor removal 
with venous replacement [21]. In contrast, palliative treatment should be regarded as the stan‐
dard of care when suspected arterial borderline resectability is intraoperatively confirmed 
as a true arterial involvement. Stratification and recognition of the patients with borderline 
findings who do not benefit from extended resections could be done with the neoadjuvant 
treatment. Patients with a clear tumor progression under neoadjuvant treatment should be 
excluded from secondary exploration.
Vascular resection must be performed only upon carefully selected patients with data for 
presence of resectable tumors or tumors with borderline resectability from the preoperative 
computed axial tomography.
5. Arterial resections
Arterial resection is usually performed in cases of advanced tumors that infiltrate the ret‐
roperitoneal nerve plexus and are related with poor prognosis. Some studies doubted the 
question whether performing of arterial resection in patients with pancreatoduodenectomy is 
necessary because the procedure itself is a technical challenge. They confirmed that the arte‐
rial resection is possible, but there were not enough data in favor, and that is why it is applied 
in the context of randomized controlled trials (RCTs) [25].
Neoadjuvant treatment should be evaluated to achieve a better local tumor control in case 
of arterial tumor infiltration. It can be performed following different study protocols and is 
not standardized yet [26]. Following the restaging, patients should be subjected to surgical 
exploration as long as no signs of systemic tumor spread are visible. Further mobilization of 
the pancreatic head could be performed. First an incision of the peritoneal layer at the liga‐
ment of Treitz from the left side is made and then is continued with clearing of the tissue 
along the artery down to the origin from the aorta via this access. This preparation is used for 
confirmation or ruling out of the tumor infiltration, so that further needed procedures could 
be determined.
As a whole, arterial resections and reconstructions are limited to the common hepatic 
artery or resections (with or without any reconstruction) of the right or left hepatic artery 
in the presence of aberrant hepatic arterial anatomy. Segmental resections of the common 
hepatic artery may be considered in isolated involvement usually in the area of branching of 
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 gastroduodenal artery [6]. The transition between the common and proper hepatic artery is 
usually long enough and makes primary anastomosis possible, when the area of gastroduo‐
denal artery is resected (Figure 3). The use of an interpositional graft from reversed saphe‐
nous vein is sometimes required. Due to the communication of the right and left hepatic 
artery inside the liver, ligation of the right hepatic artery is well tolerated, on providing 
that normal levels of the serum bilirubin and normal blood flow through the portal vein 
are maintained. Despite that, revascularization of these blood vessels is usually required 
Figure 3. Combined resection of the common/proper hepatic artery with T‐T anastomosis, along with segmental portal 
vein resection with T‐T anastomosis.
Figure 4. Distal spleno‐pancreatectomy with resection of the celiac trunk and segmental resection of SMV. Ligated 
common hepatic artery is pointed by the forceps.
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because the proximal hepatic duct receives almost all of its arterial blood flow from the right 
hepatic artery after interruption of the blood flow from the right gastric artery. The aber‐
rant right hepatic artery may be infiltrated by the tumor, when the latter reaches the celiac 
trunk (upon early bifurcation and low position of the left hepatic artery) or when the artery 
branches from the superior mesenteric artery. Replaced right hepatic artery, branching from 
the superior mesenteric artery, in contrast to the accessory hepatic arteries, represents the 
only direct arterial branch toward the right lobe of the liver. When the right hepatic artery, 
branching from the superior mesenteric artery is infiltrated along the postero‐lateral bor‐
der of the head of pancreas, the  pancreatoduodenal resection does not frequently require 
removal of these blood vessels, because the larger part of these tumors are localized more in 
front of the head of pancreas and uncinate process of pancreas. The whole common hepatic 
artery may rarely branch from the superior mesenteric artery (type IX), no identification of 
that anatomical variant and inattentive ligation of the hepatic artery requires performing of 
reconstruction.
A high rate of complete resection and favorable prognosis (estimated overall 5‐year survival 
rate of 42%) could be observed in selected patients with distal pancreatectomy with en bloc 
coeliac axis resection for locally advanced pancreatic body cancer (Figure 4) [27, 28].
6. Venous resections
The tumor invasion in the porto‐mesenteric system depends on the tumor localization and 
has no relation to the long‐term survival and recurrence. This is not a prognostic factor, but 
it is an indicator of the biological aggressiveness of the tumor [9]. Invasion of the tumor pro‐
cess in the mesenteric portal blood vessels was considered as a contraindication for radi‐
cal surgery until recently. Nowadays, this opinion has changed and vascular resections are 
considered justified if achievement of clear resection margins is possible. Radical resection 
may be performed in approximately 25—30% of the patients with preoperative diagnostic 
imaging data for invasion in the porto‐mesenteric system [1]. Superior mesenteric/portal vein 
resections are quite well studied in clinical trials and large series demonstrate equivalence in 
short‐term outcome and long‐term survival of the pancreatoduodenectomies combined with 
venous resections.
Absence of dissemination of the process toward superior mesenteric artery and celiac trunk, 
which is the prerequisite for achieving of clear resection lines, is the main principle in resec‐
tions of portal vein in the course of one duodenopancreatic resection [21]. The Japanese, as 
well as European and American experience, clearly demonstrate that positive resection lines 
are a prerequisite for recurrent lesions, as well as for lower survival. The level of infiltration of 
the tumor toward the porto‐mesenteric vein is finally determined along the course of surgical 
operation by mobilization of the specimen from the surrounding tissues and its left reposi‐
tioning to hang only from the growth. Resection of the vein and recovery of its integrity is the 
next step. It could be partial or segmental (Figure 5). Vein integrity is recovered by one of the 
following four methods:
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1. Partial tangential resection of no more than one‐third of circumference of the vein with 
suture or placing of venous patch.
2. Segmental resection with termino‐terminal veno‐venous anastomosis.
3. Segmental resection with venous prosthesis from autologous vein.
4. Segmental resection with synthetic venous prosthesis.
The ISGPS proposes a classification of porto‐mesenteric resections according to the type of 
venous reconstruction [21]:
Type 1: Partial excision of venous wall with a suture closure.
Type 2: Partial excision of venous wall with a patch closure.
Type 3: Segmental venous resection with termino‐terminal anastomosis.
Type 4: Segmental venous resection with a conduit and at least two anastomoses.
More recent classification by Tseng et al. takes in general consideration the management of 
splenic vein along with the type of reconstruction [29]:
V1—Tangential resection with saphenous vein patch.
V2—Segmental resection with splenic vein ligation and primary anastomosis.
V3—Segmental resection with splenic vein ligation and interposition graft.
V4—Segmental resection without splenic vein ligation and primary anastomosis.
V5—Segmental resection without splenic vein ligation and interposition graft.
Figure 5. Partial tangential resection of the portal vein sutured longitudinally.
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Shibata et al. divided SMV/PV resections into another four types being guided mainly from 
the localization of the resection line [30]:
1. Above and below the level of the splenic vein.
2. Above the level of the splenic vein.
3. Below the level of the splenic vein.
4. Tangential resection.
It seems that the management of the splenic vein plays a crucial role during the reconstruc‐
tion of the SMV/PV confluence [31]. The classical technique of segmental venous resection 
includes transsection and ligation of the splenic vein. In technical aspect, this maneuver 
allows complete presentation of the superior mesenteric artery medially to the superior mes‐
enteric vein, and elongation of the superior mesenteric vein and portal vein (because the latter 
blood vessels are not adducted by the splenic vein) for performing of primary venous anasto‐
mosis after segmental venous resection. The retroperitoneal dissection ends with cutting by 
sharp manner of soft tissues anteriorly to the aorta and on the right side of the so presented 
superior mesenteric artery. As a result of that the specimen remains fixed only to the superior 
mesenteric‐portal vein confluence.
Extensive 2–3 cm segment of the superior mesenteric‐portal vein confluence may be resected 
without any need for interposition of a venous graft, if the splenic vein is cut. The venous 
resection is always performed with occlusion of the incoming through superior mesenteric 
vein blood flow and heparinization before its interruption. Upper gastrointestinal tract 
bleeding could be observed due to the left‐side portal hypertension after ligation of the 
splenic vein, inferior mesenteric vein, and left gastric veins. The mobilization of the neck 
of the pancreas frequently leads to ligation of the left gastric veins. If the blood flow of 
Figure 6. Segmental resection of portal vein with T‐T venous anastomosis.
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the inferior  mesenteric vein runs into the segment of the superior mesenteric vein, which 
is to be resected, the former vein must also be cut. Upon running of superior mesenteric 
vein into the splenic vein a way of collateral venous flow is ensured (after interruption of 
the splenic vein) in retrograde direction and the cutting of splenic vein in this situation is 
usually well tolerated. Of course, it is recommendable the splenic‐portal vein confluence to 
be preserved if possible, especially when ligation and cutting of inferior mesenteric vein is 
required. Preservation of the splenic vein is possible, only when the tumor invasion of the 
superior mesenteric vein or portal vein does not include the confluence with the splenic 
vein. Preservation of the splenic‐superior mesenteric‐portal vein confluence significantly 
limits the mobilization of the portal vein and preserves the primary anastomosis of supe‐
rior mesenteric vein (following segmental resection of superior mesenteric vein), except in 
cases when the segmental resection is limited up to 2 cm or less. On account of the latter an 
interpositional graft should be placed after resection of the superior mesenteric vein with 
preservation of splenic vein in most of the patients.
Reconstruction of portal vein and superior mesenteric vein after Cattel‐Braasch maneuver is 
usually possible without creating of considerable pressure on the venous anastomosis (Figures 6 
and 7), at the same time the latter event could be avoided by implanting of a venous graft.
Segmental resection along a great extent of the porto‐mesenteric vein makes impossible the 
reconstruction with termino‐terminal anastomosis. In these cases a prosthesis (graft) is used, 
which may be an autologous one (most frequently internal jugular vein) or an artificial venous 
prosthesis.
Various types of autogenous veins have been used. Jugular, external iliac vein, great 
saphenous vein, left renal, and umbilical veins, as well as synthetic grafts could be used 
as substitutes for portal vein reconstruction. Fleming et al. reported that the superficial 
Figure 7. Segmental resection of SMV with T‐T reconstruction. Replaced right hepatic artery is pointed by the forceps.
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femoral vein is an excellent size‐matched conduit for reconstruction of the SMV or PV 
without serious complications associated with venous insufficiency in the leg [32]. The 
patency of reconstruction of the PV or SMV using superficial femoral vein (GSV) reported 
by Lee et al. was 88% at mean follow‐up of 5 months with only a few patients developing 
mild lower leg edema. Chiba University’s team [33] first reported the use of a left renal 
vein graft for reconstruction of the portal vein. No obvious left kidney dysfunction has 
been diagnosed after the removal of left renal vein graft [34]. This technique has the fol‐
lowing advantages compared with other substitutes:
1. No additional skin incision because the vein is in the same operative field.
2. Usually harvesting takes only 5–10 min.
3. Vein size is often suitable for the portal vein to be reconstructed.
Chiba et al. reported a 100% patency rate in a cohort of 35 patients using a left renal vein 
graft for portal vein reconstruction, even at long‐term follow‐up. Suzuki et al. [34] also dem‐
onstrated that reconstruction of the inferior vena cava (IVC) or PV with the left renal vein is 
a durable and safe method without adverse effects on early and long‐term renal function. 
Other veins with smaller diameters like external jugular vein also could be used. The vein is 
customized by cutting longitudinally and suturing it into a sheet or tube‐like graft in order to 
overcome size discrepancy.
Its recommended synthetic grafts need to be avoided because many resections may involve 
contaminated bile and postoperative infectious complications could occur. On the other 
hand, the placement of autologous graft prolongs operative time, which is a prerequisite for 
postoperative complications. Use of artificial vascular prosthesis also bear risks from throm‐
bosis, as well as infectious complications, which is the main reason for it not to be preferred 
by most of the medical specialists, although it decreases up to the minimum by the time of 
clamping of the portal blood flow and is completely justified in critical situation, accord‐
ing to us (Figure 8). No difference is observed regarding the hepatic function and hemo‐
dynamics of the portal blood flow in the postoperative period, compared to other patients. 
Figure 8. Large resection of the portal vein with PTFE prosthesis replacement.
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Subacute or chronical thrombosis of the graft with the formation of collaterals are observed 
in long‐term follow‐up of patients with prosthesis of the porto‐mesenteric vein. This process, 
however, is of minor clinical significance, because it does not influence the liver function 
or the pressure on the system of portal vein. Recently, a multicenter analysis reported of 
synthetic graft reconstruction after portal vein resection in pancreaticoduodenectomy. The 
overall graft patency rate after 36 procedures was 76%. Portal vein thrombosis within 30 
days after surgery occurred in 9.1%. Based on the data obtained from this study, it may be 
recommended that synthetic graft should not to be selected as a portal vein substitute if an 
autogenous vein graft is available. Synthetic graft could be used as an intraoperative tempo‐
rary portal vein shunt, followed by its removal after tumor excision combined with portal 
vein resection [35].
7. Operative techniques
Pancreaticoduodenectomy with or without vein resection should be performed in resect‐
able cases. A classical Whipple procedure or a pylorus preserving pancreaticoduodenec‐
tomy (PPPD) could be carried out. The preferred access is trough bi‐subcostal incision. The 
whole abdominal cavity is consecutively examined—the liver is palpated and intraoperative 
 ultrasonography is performed for excluding metastatic lesions. The area around the celiac 
trunk is inspected for the presence of metastatic lymph nodes or local invasion. The parietal 
and visceral peritoneum are carefully examined for carcinosis. Mobilization of duodenum 
with Kocher maneuver ensures inspection of the head of pancreas and retroperitoneum in 
the area of the inferior vena cava. This is followed by dissection of the hepatoduodenal liga‐
ment. The suspected lesions are sent for express histological examination. Resectability is 
technically assessed based on the local status of the tumor and its relation to major blood 
vessels. If resectable, radical resection is undertaken. The type of the latter is determined by 
the anatomical localization of the process. If all resection margins are free of tumor invasion, 
the surgical operation is performed according to the standard approach, but if invasion is 
suspected, the course of operation may be changed by freeing the easier for dissection parts 
of the anatomical specimen at first, and proceeding to the most difficult for dissection areas 
at the end.
Vascular resections could be finished by primary closure of the vein, end‐to‐end anastomosis, 
or a segmental resection and reconstruction with interposition graft. Venous resections can 
be performed differently depending on the location and length of tumor adherence. In cases 
when the tumor infiltration reaches the vein from the right circumference and can be excised 
with a small patch and direct closure of the defect directly without a hemodynamically rel‐
evant stenosis, latero‐tangential resection of the portal vein could be done [31, 36, 37].
The mesenteric root should be mobilized completely by resolving the attachment of the right 
hemicolon to the retroperitoneal adhesions in cases when tangential vein resection is not pos‐
sible [38]. In such a way, a greater flexibility of the mesenteric vein is achieved and this almost 
always allows approximation of the distal and proximal resection margins of the vein without 
any critical tension. A vascular graft needs to be inserted when the resected venous length 
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cannot be bridged by the direct anastomosis. A study, including a series of 110 patients under‐
going venous resection with different reconstruction techniques, revealed that no differences 
in surgical outcome were observed when different types of venous reconstruction (venorrha‐
phy, end‐to‐end anastomosis, or graft insertion) were performed [38].
Venous resection is also hampered by the need for preservation of the splenic vein, because 
this makes the direct approach to the most proximal 3–4 cm of the superior mesenteric artery 
Figure 9. Resection of SMV/PV confluence with ligation of the splenic vein with preservation of the left gastric and 
inferior mesenteric veins.
Figure 10. Resection of the proximal part of the superior mesenteric vein followed by difficult anastomosis between 
portal vein and trifurcation of the distal superior mesenteric vein.
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much more difficult. Venous resection and reconstruction may be performed either before 
the separation of the specimen from the right lateral wall of the superior mesenteric artery, 
or after the accomplishment of the mesenteric dissection by separation of the superior mes‐
enteric artery at first. Both techniques require significant pancreatic surgery experience and 
must be performed only by surgeons who have enough experience in vascular resections 
and reconstructions during pancreatoduodenal resections. The patency of the venous gastric 
drainage is a special aspect in venous resections that has to be respected in certain situations. 
The splenic vein can be closed during venous resection as the stomach is usually drained 
sufficiently via the coronary vein (if preserved) and collaterals via the short gastric veins 
(Figure 9).
A plan for reconstruction must be preliminarily drawn if the proximal part of superior mes‐
enteric vein at the site where the three major veins join is involved. Major postoperative com‐
plications may result from the ligation of veins with no adequate collateral draining. Use of 
interpositional graft may become necessary for ensuring the possibility of lateral implantation 
of collaterals if reconstruction of more than one vein is needed. The first jejunal vein, which 
passes behind the superior mesenteric artery, could usually be ligated with no consequences. 
Despite that, every larger vein must at first be clamped for checking of presence of adequate 
collateral blood draining (Figure 10).
The temporary interruption of the portal blood flow could additionally damage the usually 
cholestatic liver. Data analysis shows a tendency for significant increase of the liver enzymes 
in patients with vascular resections, which is due to the clamping of the portal blood flow 
during the resection. However, this is observed only during the early postoperative period 
and does not influence liver function afterwards. The direct termino‐terminal reconstruction 
requires fast performing of the anastomosis, independently from the clamping of the supe‐
rior mesenteric vein. In cases of isolated involvement of superior mesenteric vein, the latter 
may be clamped proximally below the confluence with the splenic vein, which allows per‐
forming of anastomosis upon partially preserved portal blood flow through the splenic vein 
with intact inferior mesenteric vein. Portal blood flow is fully recovered through the created 
anastomosis after the specimen removal. Upon resection of the spleno‐portal confluence, the 
splenic vein could be anastomized termino‐laterally to the portal vein, while usually partial 
lateral clamping of the latter is performed. Avoidance of splanchnic stasis is exceptionally 
important upon performing of pancreatoduodenal resection combined with venous resection. 
The consequent intestinal and pancreatic edema hampers accomplishing of surgery and may 
have negative consequences regarding the digestive anastomosis.
Assessment of the specimen based on anatomical pathology is of considerable significance 
regarding size of the tumor, grade of invasion in the venous wall, as well as achievement of 
clear resection margins. Tumors’ diameter is measured most precisely after its removal from 
the abdominal cavity. Resection lines are assessed during surgery with express histological 
examination after separation of 3–4 mm of the resection margin of pancreas. The presence of 
tumor cells in the vein, as well as growth of the process into the adventitia or media layer of 
venous wall reveals vascular infiltration.
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8. Outcome
The overview of literature revealed that the resection and reconstruction of porto‐mesenteric 
vein in case of pancreatoduodenal resection does not change the percentage of complica‐
tions and mortality compared to the standard surgical operation. By excluding the first series 
with regional pancreatectomy, vein resection does not have prognostic significance regarding 
the survival. Large series with radical surgical resection showed that surgical morbidity and 
mortality rates are comparable to standard pancreatic head resections [38–40]. Comparable 
complication rates between standard pancreaticoduodenectomy (PD) and pancreaticoduode‐
nectomy with vascular resection (PDVR) were reported by some studies [12, 13]. Tseng et al. 
from the MD Anderson Centre, found no survival difference in patients undergoing PD and 
PDVR [29]. Yekebas et al. found similar postoperative morbidity and mortality rates between 
PD and PDVR [41]. There are also studies that have reported increased morbidity with no 
survival benefit in PDVR [38]. The analysis of our data showed that the total level of complica‐
tions in both groups of patients does not show statistical difference, while the present one is 
due mainly to patients with venous resection and interposition of artificial graft. In patients 
with vascular resection there is higher rate of early and late bleeding and a tendency for more 
frequent need for hemotransfusions. This is especially emphasized in patients with segmen‐
tal resection and reconstruction with an artificial prosthesis. This fact is explained with the 
advanced stage of the disease, involving a larger portion of the vein and the more technically 
difficult destructive stage of surgical operation, related with higher volume of blood loss. 
The rate of relaparotomies in patients with vascular resections is not greater as compared to 
patients with no vascular resections. Regarding the porto‐mesenteric invasion, the analysis of 
the literature and our experience leads to the following conclusions:
1. Involvement of superior mesenteric artery or celiac trunk usually means mesenteric nerve 
plexus involvement, which makes impossible the achievement of clear resection lines.
2. In portal and mesenteric venous resections there is no increase of the morbidity or mortal‐
ity rates, compared to those of standard pancreatoduodenectomy.
3. The survival of patients with resection of portal vein does not differ significantly from that 
of patients with standard pancreatoduodenectomy.
Ishikawa et al. reported of 3‐year survival in 59% of the cases with unilateral invasion and 
18‐month survival in patients with bilateral invasion of the process [19]. A systematic review 
by Siriwardena suggested that PDVR was associated with a high rate of nodal metastases and 
low survival rates [42]. There is also some evidence of better survival outcomes with PDVR 
over palliative treatment [36–38]. Recently, a meta‐analysis by Zhou et al. [43] compared 19 
studies and 661 patients with venous resections during PDAC with 2247 patients undergoing 
similar operation but without vessel resection. The surgical outcome of the two groups was 
comparable. No difference in overall survival between both patient groups was found, the 
5‐year survival rate being 12.3%—superior compared with palliative treatment. Bachellier et 
al. reported 22% and 2‐year survival in 31 patients with pancreatoduodenectomy and resec‐
tion of porto‐mesenteric vein, which is close to the 24% reported for the conventional surgical 
Challenges in Pancreatic Pathology210
operation [35]. Nakagohri et al. reported absence of significant difference in the survival of 
33 patients with porto‐mesenteric venous resection compared to 48 conventional pancreato‐
duodenectomies (15 vs. 10 months; p > 0.05) [44]. Other researchers present similar results: 
Leach et al.—average survival of 20 vs. 22 months, Harrison et al.—average survival of 13 vs. 
17 months, Tseng et al.—average survival of 23.43 vs. 26.5 months, and Hartel et al.—5‐year 
survival of 22 vs. 24%. Moreover, in cases of resection of the vein and absence of histological 
verification of invasion, improvement of survival was observed, but these observations of 
Nakagohri and Hartel are still not confirmed and remain controversial [44].
Based on our experience with 356 patients with pancreatic cancer radically operated in our 
department for a 10‐year period (2006–2016)—285 pancreatoduodenectomies and 71 distal 
pancreatectomies, we could point the level of combined vascular resections of 20.2%. Seventy‐
two of the presented patients underwent pancreatic resection with simultaneous vascular 
resection—SMPV in 65 cases (44 with resection of the portal vein, 15 with resection of the 
superior mesenteric vein, 6 with resection of the porto‐mesenterial confluence), arterial in 2 
and partial resections of IVC in five cases. Combined vascular resections were done in three 
Figure 11. Survival rates depending on the type of intervention.
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cases. Twenty‐eight segmental (21 end‐to‐end anastomosis and seven interposition grafts) and 
37 partial wedge venous resections of SMPV were done. Both groups PVR and PR showed 
similarly close results in complication rates, mortality, and morbidity. Three‐ and 5‐year sur‐
vival rates were 42 and 38% in the PD group and 28 and 19% in the PVR group (Figure 11).
9. Tips and tricks
• CT with intravenous enhancement is the proper imaging modality for operative planning, 
MRI is better for searching of liver metastasis;
• Venous resection should be done at the end of resection to decrease the time of liver 
ischemia;
• Prolene 5/0 is the most used suture material;
• In cases with segmental resection direct anastomosis is the preferred method for 
reconstruction;
• Left renal vein is the ideal graft;
• Routine use of heparin is controversial—it could be changed by subcutaneous application 
of 40 mg enoxaparine twice daily.
10. Conclusions
At present, it is accepted that pancreatoduodenectomy with resection of the vein does not 
increase the postoperative risk and significantly improves survival compared with drainage 
procedures, this being supported by the results obtained from our study too. Most of the 
published series include mainly patients with exceptionally invasive tumors or patients, in 
which the infiltration of the vein is found lately during the operation with inability for dis‐
continuing of the pancreatic resection. That is why the comparison of the results with stan‐
dard pancreatectomy is not completely correct. Vascular resection must be performed only 
upon carefully selected patients with data for presence of resectable tumors or tumors with 
borderline resectability from the preoperative imaging studies. The prompt management of 
pancreatic cancer with vascular involvement should involve multidisciplinary consultation 
in high‐volume centers.
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